cro.directory
← Compare landing

Anthea Pharma vs Syngene International

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAnthea PharmaSyngene International
SummaryAnthea Pharma is an injectable CDMO in Hyderabad, India, offering development and manufacturing of vials, emulsions, lyophilized vials, and prefilled syringes. The company highlights aseptic fill and finish, terminal sterilization, lyophilization, and formulation and analytical development for clients.Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
Services
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Lyophilization (Freeze Drying)
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Discovery Research
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • GLP Toxicology
  • Analytical Method Development & Validation
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Cell-Line Development
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Biologics Development & Manufacturing
  • Upstream Processing
  • Downstream Processing
  • Bioanalysis
  • Peptide Manufacturing
  • Oligonucleotide Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Cell Therapy Manufacturing
  • mRNA Manufacturing
  • Translational Research
  • High-Throughput Screening
  • Genetic Toxicology
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • Carcinogenicity Studies
  • DART (Reproductive & Developmental Toxicology)
  • Specialized & Large-Animal Models
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Flow Cytometry Services
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Central Laboratory Services
  • Clinical Imaging Core Lab
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • ICH Stability Studies
  • Companion Diagnostics Development
  • Microbiology Services
  • Virology Services
  • Immunology & Inflammation Services
  • Oncology Specialty Services
  • CNS Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • Pathology & Histology Services
  • Genomics & Sequencing Services
  • Proteomics Services
  • Bioinformatics & Data Science
  • Device & Combination Product Services
  • HPAPI Manufacturing (High-Potency)
  • Controlled Substance Manufacturing
  • Flow Chemistry & Continuous Manufacturing
  • Solid-State Chemistry & Polymorph Screening
  • Microbial Fermentation
  • ADC Payload & Linker Synthesis
  • Bioconjugation Services
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Lipid Nanoparticle (LNP) Formulation
  • Vaccine Manufacturing
  • Microbiome / Live Biotherapeutic Manufacturing
  • Cartridge Filling
  • Lyophilization (Freeze Drying)
  • Oral Solid Dosage Manufacturing
  • Topical & Semi-Solid Manufacturing
  • Inhalation & Nasal Dosage Manufacturing
  • Ophthalmic Manufacturing
  • Technology Transfer
  • Quality Control Testing
  • Stability Testing & Storage
  • Extractables & Leachables Studies
  • Secondary Packaging & Labeling
  • Serialization & Track-and-Trace
ModalitiesData not yet provided.
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • Peptide
  • Vaccine
IndicationsData not yet provided.
  • Oncology
  • Immunology
  • Neurology
  • Psychiatry
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
  • Respiratory
  • Dermatology
  • Ophthalmology
  • Gastroenterology
  • Nephrology
  • Women's Health
PhasesData not yet provided.
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Sourcing modelsData not yet provided.
  • Full-Service Outsourcing (FSO)
  • Functional Service Provider (FSP)
Locations
  • Hyderabad, Hyderabad, Telangana, India
  • Headquarters, Bangalore, Karnataka, India
  • U.S. Biologics Facility, United States
  • U.S. Biologics Facility, San Diego, California, United States
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Anthea Pharma alternatives · Syngene International alternatives

Markdown mirror: /compare/antheapharma/syngeneintl.md